Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00493649 | Adj TC + Herceptin Early Stage Breast Cancer | completed | Phase 2 | 493 | US Oncology ResearchINDUSTRY | 1 | Nov 3, 2016 | clinicaltrials |
| NCT01077726 | A Study of Xeloda (Capecitabine) in Breast Cancer Patients With Central Nervous System (CNS) Progression | completed | Phase 2 | 3 | Hoffmann-La RocheINDUSTRY | 1 | Nov 2, 2016 | clinicaltrials |
| NCT01172223 |
| Primary Chemotherapy in Patients With HER2-positive Early Breast Cancer(LAPADO) |
| completed |
| Phase 1 / Phase 2 |
| 81 |
| Prof Dirk EllingOTHER |
| 1 |
| Nov 2, 2016 |
| clinicaltrials |
| NCT01437566 | Study of GDC-0941 or GDC-0980 With Fulvestrant Versus Fulvestrant in Advanced or Metastatic Breast Cancer in Participants Resistant to Aromatase Inhibitor Therapy | completed | Phase 2 | 318 | Genentech, Inc.INDUSTRY | 23 | Nov 2, 2016 | clinicaltrials |
| NCT01941771 | Phase II Trial With Metronomic, Capecitabine Plus Oral Vinorelbine for Metastatic Breast Cancer(XeNa) | completed | Phase 2 | 110 | University of AarhusOTHER | 1 | Oct 28, 2016 | clinicaltrials |
| NCT00575744 | Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation | completed | Phase 2 | 699 | University of ArkansasOTHER | 1 | Oct 27, 2016 | clinicaltrials |
| NCT00458237 | Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 11 | Beth Israel Deaconess Medical CenterOTHER | 1 | Oct 20, 2016 | clinicaltrials |
| NCT01617668 | A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With or Without LCL161 in Patients With Triple Negative Breast Cancer | completed | Phase 2 | 209 | Novartis PharmaceuticalsINDUSTRY | 12 | Oct 17, 2016 | clinicaltrials |
| NCT00494481 | E3 Breast Cancer Taxotere Combination | completed | Phase 2 | 64 | Genzyme, a Sanofi CompanyINDUSTRY | 5 | Sep 30, 2016 | clinicaltrials |
| NCT00811135 | A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast Cancer | completed | Phase 2 | 88 | Hoffmann-La RocheINDUSTRY | 6 | Sep 29, 2016 | clinicaltrials |
| NCT00379015 | Epirubicin and Cyclophosphamide Followed By Docetaxel and Trastuzumab in Treating Women With HER2-Positive Stage III or Stage IV Breast Cancer | completed | Phase 2 | 38 | Translational Research Center for Medical Innovation, Kobe, Hyogo, JapanOTHER | 1 | Sep 28, 2016 | clinicaltrials |
| NCT00084396 | Neoadjuvant Letrozole in Treating Postmenopausal Women With Estrogen-Receptor Positive and/or Progesterone-Receptor Positive Stage II, Stage IIIA, or Stage IIIB Breast Cancer | completed | Phase 2 | 115 | Washington University School of MedicineOTHER | 1 | Sep 26, 2016 | clinicaltrials |
| NCT00691379 | Weekly Paclitaxel/Carboplatin/Bevacizumab as First Line Therapy for Triple Negative Breast Cancer | completed | Phase 1 / Phase 2 | 46 | Hellenic Oncology Research GroupOTHER | 1 | Sep 22, 2016 | clinicaltrials |
| NCT02600299 | Effectiveness of a Psycho-educational Group (PEG) Intervention on Supportive Care and Survivorship Issues in Early-stage Breast Cancer Survivors Who Have Received Systemic Treatment | completed | Phase 2 | 80 | National University of SingaporeOTHER | 1 | Sep 22, 2016 | clinicaltrials |
| NCT00411788 | A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer | completed | Phase 2 | 11 | Yale UniversityOTHER | 1 | Sep 21, 2016 | clinicaltrials |
| NCT00887575 | Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer | completed | Phase 1 / Phase 2 | 54 | SCRI Development Innovations, LLCOTHER | 1 | Sep 7, 2016 | clinicaltrials |
| NCT00201708 | Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast Cancer | completed | Phase 2 | 56 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Sep 2, 2016 | clinicaltrials |
| NCT00148694 | Preoperative Cisplatin in Early Stage Breast Cancer | completed | Phase 2 | 27 | Dana-Farber Cancer InstituteOTHER | 1 | Aug 31, 2016 | clinicaltrials |
| NCT01674062 | A Study of Perjeta (Pertuzumab) in Combination With Herceptin (Trastuzumab) in Participants With Metastatic Breast Cancer | completed | Phase 2 | 95 | Hoffmann-La RocheINDUSTRY | 5 | Aug 22, 2016 | clinicaltrials |
| NCT01413828 | Trastuzumab Administered Concurrently or Sequentially to Anthracycline-containing Adjuvant Regimen for Breast Cancer | completed | Phase 2 / Phase 3 | 201 | Peking Union Medical College HospitalOTHER | 1 | Aug 17, 2016 | clinicaltrials |
| NCT02869230 | ROLL vs WGLL for Non-palpable Breast Lesions(ROLLvsWGLL) | completed | Phase 2 | 129 | Instituto Nacional de Cancerologia, ColumbiaOTHER_GOV | 0 | Aug 16, 2016 | clinicaltrials |
| NCT01045421 | Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies | completed | Phase 1 / Phase 2 | 273 | Millennium Pharmaceuticals, Inc.INDUSTRY | 1 | Aug 15, 2016 | clinicaltrials |
| NCT00588640 | Study of D-Methadone in Patients With Chronic Pain | completed | Phase 1 / Phase 2 | 10 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Aug 10, 2016 | clinicaltrials |
| NCT00454805 | AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer. | completed | Phase 2 | 75 | AstraZenecaINDUSTRY | 3 | Aug 3, 2016 | clinicaltrials |
| NCT00717405 | A Study of Avastin (Bevacizumab) Plus Herceptin (Trastuzumab) in Patients With Primary Inflammatory HER2-Positive Breast Cancer. | completed | Phase 2 | 52 | Hoffmann-La RocheINDUSTRY | 1 | Aug 2, 2016 | clinicaltrials |
| NCT02846428 | To Evaluate the Efficacy and Safety of Capecitabine Prior to Surgery in Women With Breast Cancer | completed | Phase 2 | 182 | Hoffmann-La RocheINDUSTRY | 1 | Jul 27, 2016 | clinicaltrials |
| NCT01252277 | Breast Cancer Risk Biomarkers in Premenopausal Women | completed | Phase 2 | 36 | Carol Fabian, MDOTHER | 1 | Jul 21, 2016 | clinicaltrials |
| NCT02778763 | Study on Efficacy and Safety of CBLB612 for Neutropenia Prophylaxis | completed | Phase 2 | 23 | BioLab 612 LLCINDUSTRY | 0 | Jul 20, 2016 | clinicaltrials |
| NCT02838225 | DA Versus DAC as Postoperative Adjuvant Treatment for Early-stage Breast Cancer | completed | Phase 2 | 300 | Peking Union Medical College HospitalOTHER | 0 | Jul 20, 2016 | clinicaltrials |
| NCT00004893 | Interleukin-12 in Treating Patients With Metastatic or Recurrent Breast Cancer | completed | Phase 2 | 5 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 19, 2016 | clinicaltrials |
| NCT02418481 | Safety and Efficiency of γδ T Cell Against Breast Cancer(Her-, er-, and pr-) | completed | Phase 1 / Phase 2 | 40 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jul 19, 2016 | clinicaltrials |
| NCT00473122 | Delayed-Immediate Breast Reconstruction | completed | Phase 2 | 200 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 15, 2016 | clinicaltrials |
| NCT00777049 | Study of Panobinostat Monotherapy in Women With HER2-negative Locally Recurrent or Metastatic Breast Cancer | completed | Phase 2 | 54 | Translational Research in OncologyOTHER | 1 | Jul 15, 2016 | clinicaltrials |
| NCT00003351 | Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer | completed | Phase 2 | 104 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 14, 2016 | clinicaltrials |
| NCT00003565 | Docetaxel in Treating Patients With Solid Tumors | completed | Phase 2 | 109 | Alliance for Clinical Trials in OncologyOTHER | 3 | Jul 14, 2016 | clinicaltrials |
| NCT00635050 | Therapy for Locally Advanced Breast Cancer Using Doxil, Paclitaxel, and Cyclophosphamide With Avastin | completed | Phase 2 | 32 | University of Alabama at BirminghamOTHER | 1 | Jul 14, 2016 | clinicaltrials |
| NCT00002998 | Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 59 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 13, 2016 | clinicaltrials |
| NCT00031720 | Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease | completed | Phase 2 | 112 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT01480583 | GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases(GRABM-B) | completed | Phase 2 | 85 | Angiochem IncINDUSTRY | 1 | Jul 13, 2016 | clinicaltrials |
| NCT00450892 | Phase I/II Study of Neoadjuvant Lapatinib in Breast Cancer | completed | Phase 1 / Phase 2 | 129 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Jul 7, 2016 | clinicaltrials |
| NCT00012025 | ICI 182780 in Treating Women With Metastatic Breast Cancer | completed | Phase 2 | 80 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 6, 2016 | clinicaltrials |
| NCT00022152 | Vinorelbine in Treating Older Women With Stage IV Breast Cancer | completed | Phase 2 | 25 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT00107510 | Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer | completed | Phase 2 | 58 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT00951665 | A Study of Trastuzumab Emtansine, Paclitaxel, and Pertuzumab in Patients With HER2-Positive, Locally Advanced or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | 107 | Genentech, Inc.INDUSTRY | 1 | Jun 24, 2016 | clinicaltrials |
| NCT00444587 | A Study of Herceptin (Trastuzumab) in Combination With 2nd-Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer. | completed | Phase 2 | 114 | Hoffmann-La RocheINDUSTRY | 8 | Jun 21, 2016 | clinicaltrials |
| NCT01008904 | Magnesium Oxide in Treating Hot Flashes in Menopausal Women With Cancer | completed | Phase 2 | 31 | Virginia Commonwealth UniversityOTHER | 0 | Jun 21, 2016 | clinicaltrials |
| NCT00291135 | Protocol for Women at Increased Risk of Developing Breast Cancer | completed | Phase 2 | 42 | Carol Fabian, MDOTHER | 1 | Jun 15, 2016 | clinicaltrials |
| NCT02794324 | The HeartSpare Study (Stage I) | completed | Phase 2 / Phase 3 | 57 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jun 9, 2016 | clinicaltrials |
| NCT01296893 | Can Exercise Improve Cancer Associated Cognitive Dysfunction?(chemobrain) | completed | Phase 2 | 31 | University of British ColumbiaOTHER | 1 | Jun 7, 2016 | clinicaltrials |
Data updated 24 days agoSource updated Nov 3, 2016source: clinicaltrials